These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 8676065

  • 1. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide.
    Brossart P, Bevan MJ.
    J Exp Med; 1996 Jun 01; 183(6):2449-58. PubMed ID: 8676065
    [Abstract] [Full Text] [Related]

  • 2. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
    Kessler B, Hudrisier D, Schroeter M, Tschopp J, Cerottini JC, Luescher IF.
    J Immunol; 1998 Dec 15; 161(12):6939-46. PubMed ID: 9862728
    [Abstract] [Full Text] [Related]

  • 3. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ, Butterfield LH, Dissette VB, Economou JS, Bonavida B.
    J Immunol; 2001 Mar 01; 166(5):3564-73. PubMed ID: 11207317
    [Abstract] [Full Text] [Related]

  • 4. Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
    Kessler BM, Bassanini P, Cerottini JC, Luescher IF.
    J Exp Med; 1997 Feb 17; 185(4):629-40. PubMed ID: 9034142
    [Abstract] [Full Text] [Related]

  • 5. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES, Abrams SI.
    J Immunol; 2000 May 01; 164(9):4941-54. PubMed ID: 10779805
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF, Green WR.
    J Immunol; 2002 Mar 15; 168(6):2751-8. PubMed ID: 11884442
    [Abstract] [Full Text] [Related]

  • 7. Self-veto mechanism of CD8+ cytotoxic effector T cells. Peptide-induced paralysis affects the peptide-MHC-recognizing cytotoxic T lymphocytes and is independent of Fas/Fas ligand interactions.
    Bergenthal A, Hofmann M, Heeg K.
    Eur J Immunol; 1998 Jun 15; 28(6):1911-22. PubMed ID: 9645373
    [Abstract] [Full Text] [Related]

  • 8. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T, Staege MS, Reichmann G, Reske-Kunz AB.
    J Immunol; 1993 Apr 01; 150(7):2575-83. PubMed ID: 8454844
    [Abstract] [Full Text] [Related]

  • 9. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
    Sakita I, Hörig H, Sun R, Wang F, Nathenson SG.
    J Immunol Methods; 1996 Jun 10; 192(1-2):105-15. PubMed ID: 8699005
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy.
    Sadovnikova E, Stauss HJ.
    Proc Natl Acad Sci U S A; 1996 Nov 12; 93(23):13114-8. PubMed ID: 8917553
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
    Schneck J, Munitz T, Coligan JE, Maloy WL, Margulies DH, Singer A.
    Proc Natl Acad Sci U S A; 1989 Nov 12; 86(21):8516-20. PubMed ID: 2813409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TCR alpha/beta and TCR gamma/delta CD4-/CD8- HLA-DR alloreactive CTL clones do not use Fas/Fas ligand pathway to lyse their specific target cells.
    Mami-Chouaib F, Flament C, Asselin-Paturel C, Gaudin C, Chouaib S.
    Hum Immunol; 1996 Nov 12; 51(1):13-22. PubMed ID: 8911993
    [Abstract] [Full Text] [Related]

  • 18. Selective induction of CD8+ cytotoxic T lymphocyte effector function by staphylococcus enterotoxin B.
    Fuller CL, Braciale VL.
    J Immunol; 1998 Nov 15; 161(10):5179-86. PubMed ID: 9820488
    [Abstract] [Full Text] [Related]

  • 19. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
    Carbone FR, Moore MW, Sheil JM, Bevan MJ.
    J Exp Med; 1988 Jun 01; 167(6):1767-79. PubMed ID: 2455012
    [Abstract] [Full Text] [Related]

  • 20. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI, Stanziale SF, Lunin SD, Zaremba S, Schlom J.
    Eur J Immunol; 1996 Feb 01; 26(2):435-43. PubMed ID: 8617315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.